Zai Lab Ltd
Elegrobart
TED
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for Elegrobart in TED are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“pivotal data readouts for povetacicept in IgAN and elegrobart in TED expected in 2026”